This compound is a nucleoside phosphoramidite building block intermediate used in pharmaceutical manufacturing. It features a protected uridine derivative with a dimethoxytrityl group and a benzamide substituent, designed for oligonucleotide synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 67219-55-0
DMT-N4-Acetyl-2'-Deoxycytidine
Pharmaceutical intermediate for oligonucleotide synthesis
N-Benzoyl-5'-O-(bis(4-methoxyphenyl)phenylmethyl)-2'-deoxy-5-methylcytidine
Nucleoside intermediate for oligonucleotide synthesis
1-N-Fmoc-2-Cyanopiperidine
Pharmaceutical intermediate
(9H-Fluoren-9-yl)methyl piperidin-3-ylcarbamate--hydrogen chloride (1/1)
Fmoc-protected piperidine intermediate
2-N-Fmoc-aminomethyl piperidine
pharmaceutical intermediate for peptide synthesis
(3R)-1-(2-aminoethyl)pyrrolidin-3-ol
Pharmaceutical intermediate
N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
nucleoside phosphoramidite building block intermediate
Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-5-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
DNA synthesis building block
N-[1-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
MYSNCIZBPUPZMQ-VOTWKOMSSA-N
COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OC[C@@H]4[C@H](C[C@@H](O4)N5C=CC(=NC5=O)NC(=O)C6=CC=CC=C6)O